Business
Dicot Pharma Signs Agreement With CRO Ahead Of Phase 2B Study With Lib-01
Dicot Pharma Signs Agreement With CRO Ahead Of Phase 2B Study With Lib-01
About this update from Dicot Pharma Ab
Dicot Pharma AB OMXSTO:DICOT:SIGNS AGREEMENT WITH CRO AHEAD OF PHASE 2B STUDY WITH LIB-01STUDY WILL BE CONDUCTED IN US AND EUROPE AND IS EXPECTED TO START DURING SECOND HALF OF 2026.